The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMercia Asset Regulatory News (MERC)

Share Price Information for Mercia Asset (MERC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 32.70
Bid: 32.00
Ask: 33.40
Change: 0.00 (0.00%)
Spread: 1.40 (4.375%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 32.70
MERC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Matt Mead appointed Chief Investment Officer

25 Mar 2015 07:00

RNS Number : 3573I
Mercia Technologies PLC
25 March 2015
 



25 March 2015

 

Mercia Technologies PLC

 

Matt Mead appointed Chief Investment Officer

 

Mercia Technologies PLC (AIM: MERC, "Mercia" or the "Group"), a Midlands based leader in the funding and commercialisation of technology businesses in the UK, is pleased to announce that Matt Mead has been appointed Chief Investment Officer with effect from 26 May 2015.

 

Matt has over 20 years' experience in the investment industry and is a seasoned board executive, having been a non-executive director and non-executive Chairman at over 15 early stage and growth businesses.

 

He worked at 3i from 1995 to 2009 making early stage investments in software and other technology businesses. He also successfully directed 3i's pan European Venture portfolio team returning a significant level of proceeds in two years and managed the disposal of 3i's Venture Portfolio in a series of secondary transactions.

 

He subsequently joined NESTA as Managing Director Investments to run its £30m Venture Capital Fund and in 2010 was appointed CIO, managing all investment activity at NESTA, including its £350m Trust assets and its social impact investment funds.

 

Mark Payton, Chief Executive of Mercia Technologies PLC, said:

 

"I am delighted to welcome Matt to Mercia Technologies as CIO. He has an excellent track record in all stages of the investment process - from identifying quality early stage opportunities, through to nurturing and scaling growth businesses for successful exit.

 

"With his broad expertise and experience, backed by a strong reputation as a smart and effective investor in emerging, innovative businesses, Matt is a valuable addition to our executive team, as we continue to develop our business into 2015."

 

 

Enquiries:

 

Mercia Technologies PLC (www.merciatechnologies.com)

+44 (0) 330 223 1430

Mark Payton, Chief Executive

Cenkos Securities

+44 (0) 20 7397 8900

Ivonne Cantu / Mark Connelly

Instinctif Partners

+44 (0) 20 7457 2020

Adrian Duffield / Kay Larsen

 

Other than the following details, there are no further details in relation to Matthew Mead to be disclosed under Rule 17 and Schedule 2 paragraph (g) of the AIM Rules.

 

Matthew Sidney Mead aged 50, is currently a director of the following companies:

 

· Kiln Ventures Limited

· Cogbooks Limited

 

During the five year period up to the date of this announcement Mathew has also served as a director of the following companies of which he is no longer a director:

 

· Nesta Partners limited

· Nesta GP Limited

· UK Business Angels Association

· Featurespace limited

· Movellas APS

 

Note to editors

 

Mercia Technologies PLC

Mercia creates, funds and develops technology businesses nationally with an emphasis in the Midlands and the North of the UK. It brings technology transfer, company formation, incubation, commercialisation and investment, to technology ventures.

 

Mercia has a well seeded portfolio and pipeline of investments. The Group has a direct investment in 11 operating companies and access to a portfolio of 38 businesses through its third party funds, managed by its wholly owned subsidiary Mercia Fund Management.

 

Mercia's shares started trading on AIM on 18 December 2014.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOASEUFMLFISEID
Date   Source Headline
20th Dec 201910:29 amRNSResult of General Meeting
9th Dec 20192:05 pmRNSSecond Price Monitoring Extn
9th Dec 20192:00 pmRNSPrice Monitoring Extension
5th Dec 20197:00 amRNSPosting of documents and Notice of GM
3rd Dec 20193:46 pmRNSResult of Accelerated Bookbuild to raise £30.0m
3rd Dec 20199:05 amRNSSecond Price Monitoring Extn
3rd Dec 20199:00 amRNSPrice Monitoring Extension
3rd Dec 20197:01 amRNSProposed Acquisition & ABB to raise £30.0million
3rd Dec 20197:00 amRNSHalf Year Results
20th Nov 20197:00 amRNSnDreams makes significant commercial progress
14th Nov 20197:00 amRNSAppointment of Joint Broker
5th Nov 201911:02 amRNSNotification of Major Holdings
4th Nov 20194:49 pmRNSNotification of Major Holdings
1st Nov 20194:31 pmRNSNotification of Major Holdings
22nd Oct 20194:54 pmRNSNotification of Major Holdings
17th Oct 20191:59 pmRNSNotification of Major Holdings
16th Oct 20197:36 amRNSNotification of Major Holdings
25th Sep 20197:00 amRNSAnnouncement of significant contract for OXGENE
24th Sep 201911:02 amRNSResult of AGM
24th Sep 20197:00 amRNSAGM Statement
10th Sep 20197:00 amRNS£7.5million syndicated investment into Voxpopme
1st Aug 20197:00 amRNSGrant of Options
29th Jul 20192:24 pmRNSNotification of Major Holdings
26th Jul 20197:00 amRNSPublication of Annual Report
8th Jul 20197:00 amRNSPreliminary Results
5th Jul 201910:00 amRNSChange of Name
2nd Jul 20197:00 amRNSDirectorate Change
21st May 20197:00 amRNS£2.4million syndicated investment into Medherant
15th May 20197:00 amRNS£2.0million syndicated investment into Locate Bio
14th May 20197:06 amRNSConcepta PLC confirms first myLotus® pregnancies
2nd May 20197:00 amRNSNotice of Preliminary Results
11th Apr 20199:41 amRNSPDMR Dealing
10th Apr 20197:00 amRNSDirector/ PDMR Dealings
28th Mar 20197:00 amRNS£6.5m syndicated investment into Oxford Genetics
18th Mar 20194:23 pmRNSPDMR / Director Dealings
15th Mar 20191:19 pmRNSPDMR / Director Dealings
12th Mar 20197:06 amRNSPortfolio company Concepta secures partnership
28th Feb 20197:00 amRNSPortfolio company announces six licensing deals
20th Feb 20197:00 amRNSSoftware & the Internet Portfolio Update
5th Feb 20197:00 amRNSAppointment of NOMAD
3rd Dec 20187:00 amRNSHalf Year Results
31st Oct 20187:00 amRNSNotice of Results
29th Oct 20187:00 amRNSNew Direct Investment in W2 Global Data Solutions
18th Oct 20187:00 amRNSCapital Markets Day
16th Oct 20187:00 amRNSNew Emerging Star investment into Locate Bio
21st Sep 201810:47 amRNSResult of AGM
21st Sep 20187:00 amRNSAGM Statement
18th Sep 20187:00 amRNSAston EyeTech secures multi-million pound contract
13th Sep 20187:00 amRNSNotice of Capital Markets Day
29th Aug 20187:00 amRNSGrant of Options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.